As per Intent Market Research, the RNA Analysis Market was valued at USD 5.5 billion in 2023-e and will surpass USD 10.3 billion by 2030; growing at a CAGR of 10.8% during 2024 - 2030. The market is thriving due to the rising interest for personalized medicines across the globe.

COVID-19 Pandemic and Post-Pandemic Transitions have significantly boosted RNA Analysis Market

The emergence of the COVID-19 pandemic significantly influenced the market, with a surge in demand for testing and diagnosis due to the severity of the SARS-CoV-2 virus infection. The pandemic prompted increased research to unravel the virus's genetic makeup, driving demand for next-generation sequencing (NGS) and polymerase chain reaction (PCR). While the initial impact was favorable, with heightened market activity during the pandemic, the current post-pandemic phase has led to a slight loss of momentum.

Increasing Investments in Pharmaceuticals for Personalized Medicine is Driving the Market

The RNA analysis market is experiencing a surge in interest due to the growing demand for personalized medicine. This is accompanied by increased investments in pharmaceutical and biotechnology research, emphasizing the industry's commitment to innovative healthcare solutions.

Role of Reagents and Consumables Supply in Fueling RNA Analysis Advancements

This segment involves the supply of chemical and biological substances essential for RNA analysis, including primers, probes, enzymes, and other consumables. The demand for reagents/consumables is directly correlated with the overall adoption and usage of RNA analysis technologies. As researchers and laboratories engage in RNA analysis processes, the consumption of reagents and consumables increases.

According to the World Health Organization's February 2022 update, cancer stands as a major global cause of mortality, with cancer-causing infections such as human papillomavirus (HPV) and hepatitis contributing to around 30% of cases in low- and lower-middle-income countries. Given the substantial burden of cancer and infectious diseases, there is an escalating demand for diagnosis in medical specialties and diagnostic care centres, projecting substantial growth for the reagents/consumables segment throughout the forecast period.

Transformative Impact of Advanced PCR Technology in the RNA Analysis Market

PCR is a fundamental technology in RNA analysis, facilitating the amplification of RNA sequences for further study. Advancements in PCR technology, such as the introduction of real-time PCR, contribute significantly to the evolution of this segment. Real-time PCR enables researchers to monitor the amplification process in real time, providing quantitative data and enhancing the precision of RNA analysis. The continuous improvement and innovation in PCR technology drive market growth by offering more efficient and accurate tools for RNA analysis applications.

Source: Intent Market Research Analysis

Drug Discovery Excellence in Identifying Potential Drug Targets is Boosting the Market

RNA analysis is a cornerstone in drug discovery and development processes. It plays a pivotal role in identifying potential drug targets and understanding gene expression patterns associated with diseases. The pharmaceutical industry heavily relies on RNA analysis to discover new therapeutic targets, assess drug efficacy, and optimize treatment strategies. The demand for RNA analysis tools and services in the drug discovery and development segment is instrumental in shaping the market landscape.

RNA Analysis Tools and Services Taking Center Stage in Pharmaceutical and Biotechnology Frontiers

The demand for RNA analysis tools and services is particularly high in the pharmaceutical and biotechnology sectors. These industries are at the forefront of drug development and research activities, relying on RNA analysis for various applications, including target identification, biomarker discovery, and understanding disease mechanisms.

Europe Market Thrives Due to the Continuous Technological Advancements in Region

The RNA analysis market in Europe experiences growth driven by active research, technological advancements in next-generation sequencing, government funding, collaborative efforts, and expanding clinical applications. Institutions and companies engage in RNA-related research, contributing to advancements in genomics and transcriptomics.

For instance, the market segment's growth is further propelled by strategic product launches from key players. For instance, in March 2021, PCR Biosystems, a UK-based company introduced the IsoFast BST Polymerase reagents range for rapid, robust, and sensitive RNA amplification. These product approvals are poised to significantly contribute to the segment's growth during the forecast period.

Major Industry Players are Enhancing their Positions in the RNA Analysis Market

The market is characterized by intense competition due to the presence of numerous international and domestic players. The RNA analysis market, in particular, is dominated by key players such as Agilent, Basepair, BioMérieux, Bio-Rad Laboratories, Eurofins, GenXPro, Illumina, Promega Corporation, Qiagen, Roche, Thermo Fisher Scientific, amongst others.  

Pioneering Product Developments and Strategic Acquisitions Drive Growth in the RNA Analysis Industry

The integration of personalized medicine into mainstream clinical practice has revolutionized disease detection, classification, and treatment. This paradigm shift is particularly evident in oncology, where tailored medications, therapies, and diagnostic tests have become more prevalent. As per the American Cancer Society, the increasing burden of cancer worldwide, with an estimated 29.0 million cases by 2040, contributes to the growing demand for RNA analysis products to develop innovative precision medicines for cancer.

Market players are actively contributing to growth through product developments and innovations. For instance, in April 2022, Lexogen's introduced CORALL RNA-Seq V2 whole transcriptome library prep kit, a cutting-edge technology enabling comprehensive RNA molecule determination in samples. Additionally, a strategic initiative in January 2021 by Merck acquired AmpTec to enhance mRNA development capabilities. Through the acquisition, Merck will be better equipped to research, develop, and produce mRNA for its clients' usage in COVID-19 and other disease-specific therapies, diagnostics, and vaccinations, which are anticipated to bolster market growth.

RNA Analysis Market Coverage

The report provides key insights into the RNA analysis market, and it focuses on technological developments, trends, and initiatives taken by the government in this sector. The report delves into market drivers, restraints, and opportunities, and analyses key players and the competitive landscape within the market. The report offers the market size and forecasts for the RNA analysis market in value (USD billion) for all the above segments.

Report Scope